New Insights into OPHN1-Related Neurodevelopmental Disorders: Clinical and Genetic Discoveries Including Novel Variants
Overview of OPHN1-Associated Neurodevelopmental Disorders
Pathogenic variants in the OPHN1 gene have been linked to an X-linked intellectual developmental disorder known as Billuart type (OMIM #300486). This condition typically manifests with intellectual disability, distinct facial characteristics, cerebellar abnormalities, ventriculomegaly (enlarged brain ventricles), epilepsy, and a range of neuropsychiatric symptoms.
Study Summary and Key Findings
A recent study examined four male patients from unrelated families in Türkiye, all presenting with intellectual disability and developmental delays. Comprehensive clinical evaluations, neuroimaging, and genetic analyses—including whole-exome or clinical exome sequencing—were performed to better understand their conditions.
Genetic testing revealed hemizygous variants in the OPHN1 gene in all four individuals. Two of these were loss-of-function variants: a nonsense mutation (c.226del, leading to p.Leu76Ter) and a frameshift mutation (c.226_227del, resulting in p.Leu76AspfsTer2). Both are predicted to cause premature stop codons and consequent loss of normal protein function, and were classified as pathogenic or likely pathogenic.
Additionally, two intronic splice-site variants (c.1527-3 C>G and c.2158+5G>A) were identified. Although these were classified as variants of uncertain significance, computational analyses strongly suggested that they may disrupt normal RNA splicing, potentially affecting gene function.
Clinical and Neuropsychiatric Features Observed
The affected individuals exhibited clinical features consistent with previously described OPHN1-related phenotypes, including developmental delay, varying degrees of intellectual disability, characteristic facial features, and abnormalities in cerebellar and ventricular brain structures. Notably, neuropsychiatric manifestations such as autism spectrum disorder and hyperactivity were also reported, underscoring the phenotypic variability associated with OPHN1 mutations.
Significance and Implications for Families
This study represents the first report of OPHN1-related neurodevelopmental disorders in patients from Türkiye and expands the known molecular and clinical spectrum by identifying three novel OPHN1 variants. The findings reinforce the importance of considering both loss-of-function and splice-site variants in the diagnostic evaluation of patients with intellectual disability and related neurological features.
For families, these insights may improve genetic counseling and help guide clinical management by providing a clearer understanding of the potential range of symptoms and outcomes associated with OPHN1 mutations.
Limitations and Considerations
While the study highlights novel genetic variants and associated clinical features, some splice-site variants remain classified as uncertain significance pending further functional validation. Additionally, the small sample size limits broader generalizations. As with all genetic research, findings should be interpreted cautiously and in the context of comprehensive clinical evaluation.
For more detailed information, the original study can be accessed here.
Download the images in this article
